Adaptimmune Therapeutics News

Adaptimmune Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%), etc.

Apr 2 20:41 ET

Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC

Mar 26 12:04 ET

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.

Mar 26 12:04 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia

Mar 18 17:01 ET

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.

Feb 14 17:49 ET

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.

Feb 14 17:11 ET

Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.

Jan 30 17:29 ET

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.01%)

Jan 29 11:53 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lunger John

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Norry Elliot

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hege Kristen

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lunger John

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brewer Joanna Elizabeth

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer TAYTON-MARTIN HELEN KATRINA

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian

Jan 17 00:00 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Norry Elliot

Jan 17 00:00 ET